These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27637748)

  • 1. Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.
    Sun LH; Yang FQ; Zhang CB; Wu YP; Liang JS; Jin S; Wang Z; Wang HJ; Bao ZS; Yang ZX; Jiang T
    CNS Neurosci Ther; 2017 Jan; 23(1):69-75. PubMed ID: 27637748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased BRMS1L expression is correlated with glioma grade and predicts poor survival in glioblastoma via an invasive phenotype.
    Lv J; Yang H; Wang X; He R; Ding L; Sun X
    Cancer Biomark; 2018; 22(2):311-316. PubMed ID: 29660900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
    Wu DW; Cheng YW; Wang J; Chen CY; Lee H
    Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.
    Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H
    Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer analysis reveals an immunological role and prognostic potential of PXN in human cancer.
    Chen Y; Zhao H; Xiao Y; Shen P; Tan L; Zhang S; Liu Q; Gao Z; Zhao J; Zhao Y; Guo Y; Feng Y
    Aging (Albany NY); 2021 Jun; 13(12):16248-16266. PubMed ID: 34135128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer.
    Chen DL; Wang ZQ; Ren C; Zeng ZL; Wang DS; Luo HY; Wang F; Qiu MZ; Bai L; Zhang DS; Wang FH; Li YH; Xu RH
    J Transl Med; 2013 Nov; 11():277. PubMed ID: 24180516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.
    Li L; Wang J; Gao L; Gong L
    Int J Clin Exp Pathol; 2015; 8(8):9232-9. PubMed ID: 26464671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis.
    Huang Z; Wang H; Sun D; Liu J
    Biomed Res Int; 2022; 2022():7171126. PubMed ID: 35782068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
    Patil V; Mahalingam K
    Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CDC5L is associated with tumor progression in gliomas.
    Chen W; Zhang L; Wang Y; Sun J; Wang D; Fan S; Ban N; Zhu J; Ji B; Wang Y
    Tumour Biol; 2016 Mar; 37(3):4093-103. PubMed ID: 26490980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells.
    Du C; Wang X; Zhang J; Liu X; Zhu J; Liu Y
    Oncol Rep; 2016 Jan; 35(1):409-17. PubMed ID: 26530439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The overexpression of PXN promotes tumor progression and leads to radioresistance in cervical cancer.
    Liu Q; Wang J; Tang M; Chen L; Qi X; Li J; Yu J; Qiu H; Wang Y
    Future Oncol; 2018 Feb; 14(3):241-253. PubMed ID: 29318915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
    Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
    Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
    Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
    Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
    [No Abstract]   [Full Text] [Related]  

  • 16. KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4.
    Sun L; Zhang C; Yang Z; Wu Y; Wang H; Bao Z; Jiang T
    Oncotarget; 2016 Apr; 7(17):24646-55. PubMed ID: 27013586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
    Wang H; Jiang C
    Oncol Rep; 2013 Nov; 30(5):2350-6. PubMed ID: 24026199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas.
    Bao Z; Zhang C; Yan W; Liu Y; Li M; Zhang W; Jiang T
    J Transl Med; 2013 Apr; 11():100. PubMed ID: 23590708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
    Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
    Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.